The overall quality of evidence for this outcome was low due to serious imprecision (low number of trials and participants)
Published: Oct 20, 2025 Written by Klarity Editorial Team Published: Oct 20, 2025 If youre experiencing lightheadedness while taking Ozempic, Mounjaro, or other GLP-1 medications, youre not alone
Your healthcare provider can determine if your current GLP-1 regimen remains sufficient or if optimization is necessary
The FDA has indicated it will remove the seven compounds from the interim Category 2 restricted list while the July review proceeds
However, it is essential to understand which molecules and extracts have a proven track record in terms of efficacy, while taking safety considerations into account
Your familys well-being is our top priority, and we are deeply committed to providing personalized care and support